Back
Fennec Pharmaceuticals, Inc. 10K Form
Sell
17
FENC
Fennec Pharmaceuticals, Inc.
Last Price:
$6.42
Seasonality Move:
7.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FENC News And Ratings
See the #1 stock for the next 7 days that we like better than FENC
FENC Financial Statistics
Sales & Book Value
| Annual Sales: | $44.6M |
|---|---|
| Cash Flow: | $-7.8M |
| Price / Cash Flow: | 7.15 |
| Annual Sales: | $1.04 |
| Price / Book: | 6.24 |
Profitability
| EPS (TTM): | -0.34400 |
|---|---|
| Net Income (TTM): | $-10.1M |
| Gross Margin: | $40.9M |
| Return on Equity: | -429.2% |
| Return on Assets: | -19.72% |
Fennec Pharmaceuticals, Inc. Earnings Forecast
Key Fennec Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for FENC is 91.57%.
-
The Selling, General & Administrative Expenses for FENC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.56% of Revenue.
-
The Net Earning history of FENC is -21.82% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
Fennec Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FENC |
| CUSIP: | 31447P |
| Website: | fennecpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.37 |
| Quick Ratio: | 6.27 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 7.09 |
FENC Technical Analysis vs Fundamental Analysis
Sell
17
Fennec Pharmaceuticals, Inc. (FENC)
is a Sell
Is Fennec Pharmaceuticals, Inc. a Buy or a Sell?
-
Fennec Pharmaceuticals, Inc. stock is rated a SellThe current Fennec Pharmaceuticals, Inc. [FENC] share price is $6.42. The Score for FENC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.